Investor Relations

SEC Filings

Document Details

Filing Date
Mar 11, 2022
Document Date
Mar 11, 2022
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.